

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intracellular pH reduction (GO:0051452) | 7.67469144 |
| 2 | regulation of phospholipase A2 activity (GO:0032429) | 7.57830087 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 6.73484881 |
| 4 | sphingolipid catabolic process (GO:0030149) | 6.59837151 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.50303449 |
| 6 | pinocytosis (GO:0006907) | 6.49104350 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.44310851 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.44310851 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 6.44310851 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 6.44310851 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 6.44310851 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.44310851 |
| 13 | pH reduction (GO:0045851) | 6.16591777 |
| 14 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 6.15552398 |
| 15 | glycolipid catabolic process (GO:0019377) | 6.02701488 |
| 16 | microglial cell activation (GO:0001774) | 5.99545623 |
| 17 | membrane lipid catabolic process (GO:0046466) | 5.91687243 |
| 18 | ceramide catabolic process (GO:0046514) | 5.90430459 |
| 19 | cellular response to exogenous dsRNA (GO:0071360) | 5.74404254 |
| 20 | positive regulation of mast cell degranulation (GO:0043306) | 5.41128153 |
| 21 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.41128153 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 5.31496753 |
| 23 | oligosaccharide catabolic process (GO:0009313) | 4.97907031 |
| 24 | positive regulation of mast cell activation (GO:0033005) | 4.97348855 |
| 25 | respiratory burst (GO:0045730) | 4.86796725 |
| 26 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.86695816 |
| 27 | T cell costimulation (GO:0031295) | 4.74445962 |
| 28 | lymphocyte costimulation (GO:0031294) | 4.69212024 |
| 29 | regulation of antigen processing and presentation (GO:0002577) | 4.68124612 |
| 30 | positive regulation of interferon-alpha production (GO:0032727) | 4.66371337 |
| 31 | histamine transport (GO:0051608) | 4.62353562 |
| 32 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.57192029 |
| 33 | response to peptidoglycan (GO:0032494) | 4.51661972 |
| 34 | membrane raft organization (GO:0031579) | 4.49188655 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.41964085 |
| 36 | response to host immune response (GO:0052572) | 4.41964085 |
| 37 | adenosine receptor signaling pathway (GO:0001973) | 4.40414890 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 4.36752234 |
| 39 | grooming behavior (GO:0007625) | 4.31509591 |
| 40 | righting reflex (GO:0060013) | 4.29842098 |
| 41 | intraciliary transport (GO:0042073) | 4.25974377 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.23323681 |
| 43 | macrophage activation (GO:0042116) | 3.99414673 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.99322482 |
| 45 | positive regulation of interleukin-12 production (GO:0032735) | 3.95405944 |
| 46 | regulation of intracellular pH (GO:0051453) | 3.92723414 |
| 47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.91586248 |
| 48 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.89041703 |
| 49 | regulation of lymphocyte migration (GO:2000401) | 3.88541615 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 3.87071134 |
| 51 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.85641612 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.84176574 |
| 53 | response to host (GO:0075136) | 3.84176574 |
| 54 | response to host defenses (GO:0052200) | 3.84176574 |
| 55 | superoxide anion generation (GO:0042554) | 3.76691309 |
| 56 | cellular response to interferon-beta (GO:0035458) | 3.72620834 |
| 57 | cellular protein catabolic process (GO:0044257) | 3.68784924 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68319989 |
| 59 | behavioral response to ethanol (GO:0048149) | 3.67116856 |
| 60 | positive regulation of T cell migration (GO:2000406) | 3.66858154 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.66035762 |
| 62 | defense response to protozoan (GO:0042832) | 3.64971863 |
| 63 | indole-containing compound catabolic process (GO:0042436) | 3.63289758 |
| 64 | indolalkylamine catabolic process (GO:0046218) | 3.63289758 |
| 65 | tryptophan catabolic process (GO:0006569) | 3.63289758 |
| 66 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.58029381 |
| 67 | regulation of cellular pH (GO:0030641) | 3.57713659 |
| 68 | reflex (GO:0060004) | 3.53764528 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.52029275 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.51946120 |
| 71 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.49728957 |
| 72 | import into cell (GO:0098657) | 3.48207750 |
| 73 | pantothenate metabolic process (GO:0015939) | 3.44910612 |
| 74 | positive regulation of leukocyte degranulation (GO:0043302) | 3.43693358 |
| 75 | regulation of calcium-mediated signaling (GO:0050848) | 3.39469044 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.38635753 |
| 77 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.37592186 |
| 78 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.37543944 |
| 79 | GTP biosynthetic process (GO:0006183) | 3.37196165 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.36816474 |
| 81 | regulation of monocyte chemotaxis (GO:0090025) | 3.36339138 |
| 82 | iron ion import (GO:0097286) | 3.35643167 |
| 83 | neutrophil activation involved in immune response (GO:0002283) | 3.34898846 |
| 84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.34006542 |
| 85 | positive regulation of prostaglandin secretion (GO:0032308) | 3.33417329 |
| 86 | Rac protein signal transduction (GO:0016601) | 3.32747685 |
| 87 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.31779006 |
| 88 | cytokine biosynthetic process (GO:0042089) | 3.31713347 |
| 89 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.30274525 |
| 90 | activated T cell proliferation (GO:0050798) | 3.27038842 |
| 91 | apoptotic DNA fragmentation (GO:0006309) | 3.26083578 |
| 92 | positive regulation of lymphocyte migration (GO:2000403) | 3.23491199 |
| 93 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.22293106 |
| 94 | thrombin receptor signaling pathway (GO:0070493) | 3.21339196 |
| 95 | positive regulation of interleukin-17 production (GO:0032740) | 3.15355605 |
| 96 | regulation of T cell migration (GO:2000404) | 3.15262771 |
| 97 | protein K11-linked deubiquitination (GO:0035871) | 3.14934659 |
| 98 | kynurenine metabolic process (GO:0070189) | 3.14123331 |
| 99 | positive regulation of type 2 immune response (GO:0002830) | 3.11395590 |
| 100 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.10725514 |
| 101 | multicellular organism reproduction (GO:0032504) | 3.09988355 |
| 102 | tryptophan metabolic process (GO:0006568) | 3.09125203 |
| 103 | B cell mediated immunity (GO:0019724) | 3.08967207 |
| 104 | phagocytosis, engulfment (GO:0006911) | 3.08720310 |
| 105 | regulation of acrosome reaction (GO:0060046) | 3.08378897 |
| 106 | developmental programmed cell death (GO:0010623) | 3.06048701 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06042707 |
| 108 | immunoglobulin mediated immune response (GO:0016064) | 3.05160299 |
| 109 | response to protozoan (GO:0001562) | 3.04967893 |
| 110 | germinal center formation (GO:0002467) | 3.03753898 |
| 111 | T cell receptor signaling pathway (GO:0050852) | 3.02295073 |
| 112 | I-kappaB phosphorylation (GO:0007252) | 3.00734146 |
| 113 | azole transport (GO:0045117) | 2.99822942 |
| 114 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.99325638 |
| 115 | response to muramyl dipeptide (GO:0032495) | 2.99069919 |
| 116 | CTP biosynthetic process (GO:0006241) | 2.97123333 |
| 117 | CTP metabolic process (GO:0046036) | 2.97123333 |
| 118 | Golgi to endosome transport (GO:0006895) | 2.96003196 |
| 119 | actin nucleation (GO:0045010) | 2.95984081 |
| 120 | regulation of tolerance induction (GO:0002643) | 2.95824266 |
| 121 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.95128733 |
| 122 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.92903025 |
| 123 | early endosome to late endosome transport (GO:0045022) | 2.92595419 |
| 124 | regulation of interleukin-12 production (GO:0032655) | 2.91077826 |
| 125 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.90206728 |
| 126 | rRNA catabolic process (GO:0016075) | 2.89923377 |
| 127 | positive regulation of heat generation (GO:0031652) | 2.88390091 |
| 128 | regulation of activation of Janus kinase activity (GO:0010533) | 2.88369520 |
| 129 | regulation of fever generation (GO:0031620) | 2.88209656 |
| 130 | negative regulation of B cell proliferation (GO:0030889) | 2.86868206 |
| 131 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.86352266 |
| 132 | neutrophil activation (GO:0042119) | 2.86221759 |
| 133 | ganglioside metabolic process (GO:0001573) | 2.86163707 |
| 134 | glycoside metabolic process (GO:0016137) | 2.85838450 |
| 135 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85804602 |
| 136 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.84981235 |
| 137 | platelet dense granule organization (GO:0060155) | 2.84338500 |
| 138 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.83928074 |
| 139 | positive regulation of interleukin-6 production (GO:0032755) | 2.83515475 |
| 140 | response to pheromone (GO:0019236) | 2.81572000 |
| 141 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.80454601 |
| 142 | myeloid leukocyte activation (GO:0002274) | 2.79632033 |
| 143 | regulation of mast cell activation (GO:0033003) | 2.79534921 |
| 144 | positive regulation of T cell chemotaxis (GO:0010820) | 2.79418569 |
| 145 | regulation of T cell chemotaxis (GO:0010819) | 2.79418569 |
| 146 | histamine secretion (GO:0001821) | 2.79228951 |
| 147 | positive regulation of interferon-beta production (GO:0032728) | 2.77653113 |
| 148 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77594597 |
| 149 | negative regulation of mast cell activation (GO:0033004) | 2.76743541 |
| 150 | regulation of chronic inflammatory response (GO:0002676) | 2.76704292 |
| 151 | cellular biogenic amine catabolic process (GO:0042402) | 2.74580402 |
| 152 | amine catabolic process (GO:0009310) | 2.74580402 |
| 153 | indolalkylamine metabolic process (GO:0006586) | 2.73955497 |
| 154 | piRNA metabolic process (GO:0034587) | 2.73735576 |
| 155 | signal peptide processing (GO:0006465) | 2.72674763 |
| 156 | regulation of meiosis I (GO:0060631) | 2.72601851 |
| 157 | cellular response to interferon-gamma (GO:0071346) | 2.72348992 |
| 158 | cytokine metabolic process (GO:0042107) | 2.72075489 |
| 159 | regulation of heat generation (GO:0031650) | 2.71173116 |
| 160 | autophagic vacuole fusion (GO:0000046) | 2.70947921 |
| 161 | response to interferon-gamma (GO:0034341) | 2.70659759 |
| 162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70370646 |
| 163 | regulation of mast cell degranulation (GO:0043304) | 2.69739396 |
| 164 | regulation of prostaglandin secretion (GO:0032306) | 2.69639617 |
| 165 | detection of bacterium (GO:0016045) | 2.68719422 |
| 166 | myeloid cell activation involved in immune response (GO:0002275) | 2.68559000 |
| 167 | detection of other organism (GO:0098543) | 2.68432643 |
| 168 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.67438091 |
| 169 | purinergic receptor signaling pathway (GO:0035587) | 2.67241001 |
| 170 | interferon-gamma production (GO:0032609) | 2.67183455 |
| 171 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.66921171 |
| 172 | positive regulation of interferon-gamma production (GO:0032729) | 2.66743334 |
| 173 | L-amino acid import (GO:0043092) | 2.66624969 |
| 174 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.66165441 |
| 175 | C4-dicarboxylate transport (GO:0015740) | 2.64455478 |
| 176 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.63937014 |
| 177 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.63251542 |
| 178 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.63163531 |
| 179 | regulation of female gonad development (GO:2000194) | 2.62327902 |
| 180 | positive regulation of T cell activation (GO:0050870) | 2.61185245 |
| 181 | UTP biosynthetic process (GO:0006228) | 2.57297032 |
| 182 | tongue development (GO:0043586) | 2.56397270 |
| 183 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55909904 |
| 184 | negative thymic T cell selection (GO:0045060) | 2.55326495 |
| 185 | positive regulation of T cell proliferation (GO:0042102) | 2.53524485 |
| 186 | negative T cell selection (GO:0043383) | 2.52302560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.07645404 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59018495 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.44951755 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.20637044 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.11387760 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.59832292 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.17942087 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.03851268 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.00534019 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65507127 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.62506738 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.52250753 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.48859379 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.41384391 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36940198 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34025539 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.32112243 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29721761 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27120194 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25973849 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16426852 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01265615 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96461470 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93300286 |
| 25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93295885 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.91711413 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.91711413 |
| 28 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90130381 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87666347 |
| 30 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.87174742 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85844527 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.80254985 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.76867622 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.75849809 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.75073507 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.73106198 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67150631 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66370242 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65592289 |
| 40 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.61160557 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.61092159 |
| 42 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.61092159 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.55093910 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54030667 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53141244 |
| 46 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.52970275 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52081495 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.50884715 |
| 49 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.50761306 |
| 50 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.48388939 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48382757 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48330866 |
| 53 | AR_20517297_ChIP-Seq_VCAP_Human | 1.47739437 |
| 54 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.46855372 |
| 55 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.46717799 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45282485 |
| 57 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.44515218 |
| 58 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.43759055 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43139038 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.42508405 |
| 61 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.41615172 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.39825517 |
| 63 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.38400240 |
| 64 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.37533098 |
| 65 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.36704916 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36704509 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36601955 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36590651 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34700357 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33690286 |
| 71 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.33642774 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33059721 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33000029 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.32423479 |
| 75 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.31863760 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31042544 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30922575 |
| 78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29883974 |
| 79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29000228 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28473890 |
| 81 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.28391154 |
| 82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28066541 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27415355 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26619058 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25785996 |
| 86 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25690566 |
| 87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25432071 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23664914 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23378501 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.22316121 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22308681 |
| 92 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.21585951 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.20065403 |
| 94 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.20041070 |
| 95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19122096 |
| 96 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19019744 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18638448 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18638448 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18112272 |
| 100 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.17219671 |
| 101 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17014964 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16405243 |
| 103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14971125 |
| 104 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.14561541 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14441670 |
| 106 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.14338425 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14290103 |
| 108 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.14289745 |
| 109 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14132702 |
| 110 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.13875953 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13402375 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12229431 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12013108 |
| 114 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11869368 |
| 115 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11339825 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10968176 |
| 117 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.10511697 |
| 118 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09754237 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08473602 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07964294 |
| 121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06279160 |
| 122 | MYB_26560356_Chip-Seq_TH2_Human | 1.05904645 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05809957 |
| 124 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05588203 |
| 125 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05115951 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05115951 |
| 127 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05114339 |
| 128 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04933539 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04311778 |
| 130 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.03655865 |
| 131 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03605826 |
| 132 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03525646 |
| 133 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03512417 |
| 134 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02849842 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02481595 |
| 136 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.02389651 |
| 137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02286535 |
| 138 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02273291 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02267815 |
| 140 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01811211 |
| 141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00414129 |
| 142 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95625992 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95372924 |
| 144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95270252 |
| 145 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95205153 |
| 146 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.93873777 |
| 147 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93342063 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93174149 |
| 149 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92691290 |
| 150 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91801724 |
| 151 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91525812 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90346496 |
| 153 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89750250 |
| 154 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.89326950 |
| 155 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89308041 |
| 156 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88861075 |
| 157 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88590411 |
| 158 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88371494 |
| 159 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.84010631 |
| 160 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82760439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 7.97766155 |
| 2 | MP0006082_CNS_inflammation | 5.00421799 |
| 3 | MP0003136_yellow_coat_color | 3.64371898 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.63972273 |
| 5 | MP0005671_abnormal_response_to | 3.59118770 |
| 6 | MP0004147_increased_porphyrin_level | 3.53189451 |
| 7 | MP0009785_altered_susceptibility_to | 3.20261522 |
| 8 | MP0004510_myositis | 3.15173090 |
| 9 | MP0003878_abnormal_ear_physiology | 2.96305147 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 2.96305147 |
| 11 | MP0005387_immune_system_phenotype | 2.84749106 |
| 12 | MP0001790_abnormal_immune_system | 2.84749106 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.79861256 |
| 14 | MP0002419_abnormal_innate_immunity | 2.68370437 |
| 15 | MP0005025_abnormal_response_to | 2.57505897 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.57098388 |
| 17 | MP0000685_abnormal_immune_system | 2.54363406 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.48021486 |
| 19 | MP0005408_hypopigmentation | 2.41497051 |
| 20 | MP0003436_decreased_susceptibility_to | 2.41036678 |
| 21 | MP0001853_heart_inflammation | 2.25323684 |
| 22 | MP0001800_abnormal_humoral_immune | 2.22712174 |
| 23 | MP0002723_abnormal_immune_serum | 2.18402021 |
| 24 | MP0002090_abnormal_vision | 2.17621654 |
| 25 | * MP0001819_abnormal_immune_cell | 2.15255626 |
| 26 | MP0003724_increased_susceptibility_to | 2.10667121 |
| 27 | MP0001188_hyperpigmentation | 2.04888309 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.04166765 |
| 29 | MP0009046_muscle_twitch | 2.02486638 |
| 30 | MP0002006_tumorigenesis | 1.98564401 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.89515020 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.87066148 |
| 33 | MP0003195_calcinosis | 1.84284183 |
| 34 | MP0005171_absent_coat_pigmentation | 1.82117612 |
| 35 | MP0003880_abnormal_central_pattern | 1.78940915 |
| 36 | MP0002163_abnormal_gland_morphology | 1.71984187 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.71831950 |
| 38 | MP0002405_respiratory_system_inflammati | 1.70329057 |
| 39 | MP0009764_decreased_sensitivity_to | 1.69908929 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.67236602 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.66994470 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.63228910 |
| 43 | MP0002102_abnormal_ear_morphology | 1.59525562 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.56180805 |
| 45 | MP0003646_muscle_fatigue | 1.55295018 |
| 46 | MP0005360_urolithiasis | 1.54925019 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.52505502 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.45135492 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.39065813 |
| 50 | MP0003718_maternal_effect | 1.37357323 |
| 51 | MP0000716_abnormal_immune_system | 1.36973708 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.34046446 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.30680182 |
| 54 | MP0003303_peritoneal_inflammation | 1.28120171 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.26575950 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.25576346 |
| 57 | MP0003252_abnormal_bile_duct | 1.24744083 |
| 58 | MP0005253_abnormal_eye_physiology | 1.24643960 |
| 59 | MP0003941_abnormal_skin_development | 1.24491643 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.18984195 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.16936794 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.15905443 |
| 63 | MP0005310_abnormal_salivary_gland | 1.15756329 |
| 64 | MP0000427_abnormal_hair_cycle | 1.14389249 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.13880329 |
| 66 | MP0001873_stomach_inflammation | 1.13264288 |
| 67 | MP0005409_darkened_coat_color | 1.12065881 |
| 68 | MP0002398_abnormal_bone_marrow | 1.10630616 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.09913301 |
| 70 | MP0008469_abnormal_protein_level | 1.09142790 |
| 71 | MP0003879_abnormal_hair_cell | 1.08151964 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.07373860 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.05806475 |
| 74 | MP0004142_abnormal_muscle_tone | 1.05635114 |
| 75 | MP0005451_abnormal_body_composition | 1.02212296 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.01783473 |
| 77 | MP0000371_diluted_coat_color | 1.01526246 |
| 78 | MP0001186_pigmentation_phenotype | 1.01246862 |
| 79 | MP0003075_altered_response_to | 1.00675152 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 0.99275540 |
| 81 | MP0008872_abnormal_physiological_respon | 0.98818228 |
| 82 | MP0002429_abnormal_blood_cell | 0.98131229 |
| 83 | MP0002736_abnormal_nociception_after | 0.96911675 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 0.96528595 |
| 85 | MP0004782_abnormal_surfactant_physiolog | 0.96135931 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.91277324 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.91086202 |
| 88 | MP0001984_abnormal_olfaction | 0.88092337 |
| 89 | MP0004043_abnormal_pH_regulation | 0.86973109 |
| 90 | MP0001756_abnormal_urination | 0.86177316 |
| 91 | MP0000343_altered_response_to | 0.86035577 |
| 92 | MP0001293_anophthalmia | 0.85629770 |
| 93 | MP0000383_abnormal_hair_follicle | 0.85397719 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.85310777 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.83782703 |
| 96 | MP0002098_abnormal_vibrissa_morphology | 0.83488663 |
| 97 | MP0002735_abnormal_chemical_nociception | 0.82291139 |
| 98 | MP0001324_abnormal_eye_pigmentation | 0.82094005 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.81321449 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.79928865 |
| 101 | MP0008004_abnormal_stomach_pH | 0.79834265 |
| 102 | MP0001663_abnormal_digestive_system | 0.79526947 |
| 103 | MP0005670_abnormal_white_adipose | 0.78275344 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.78151808 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.78082409 |
| 106 | MP0000858_altered_metastatic_potential | 0.77763247 |
| 107 | MP0004484_altered_response_of | 0.77626242 |
| 108 | MP0002928_abnormal_bile_duct | 0.76823143 |
| 109 | MP0001919_abnormal_reproductive_system | 0.76294372 |
| 110 | MP0002722_abnormal_immune_system | 0.75837402 |
| 111 | MP0002272_abnormal_nervous_system | 0.74760013 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74709449 |
| 113 | MP0003045_fibrosis | 0.74663708 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.74657357 |
| 115 | MP0008260_abnormal_autophagy | 0.72356461 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.72167242 |
| 117 | MP0005195_abnormal_posterior_eye | 0.70843253 |
| 118 | MP0000026_abnormal_inner_ear | 0.70654845 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.69936966 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.68753696 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.67991171 |
| 122 | MP0003448_altered_tumor_morphology | 0.67370731 |
| 123 | MP0009115_abnormal_fat_cell | 0.66622570 |
| 124 | MP0001119_abnormal_female_reproductive | 0.66456514 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.65514065 |
| 126 | MP0005174_abnormal_tail_pigmentation | 0.65494435 |
| 127 | MP0002075_abnormal_coat/hair_pigmentati | 0.65394839 |
| 128 | MP0003943_abnormal_hepatobiliary_system | 0.65066973 |
| 129 | MP0002234_abnormal_pharynx_morphology | 0.64781242 |
| 130 | MP0005166_decreased_susceptibility_to | 0.63976934 |
| 131 | MP0003763_abnormal_thymus_physiology | 0.63049773 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.61682766 |
| 133 | MP0001545_abnormal_hematopoietic_system | 0.61682766 |
| 134 | MP0002095_abnormal_skin_pigmentation | 0.61412788 |
| 135 | MP0004947_skin_inflammation | 0.58896026 |
| 136 | MP0002933_joint_inflammation | 0.57529180 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.55765301 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.54514593 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.53584619 |
| 140 | MP0002572_abnormal_emotion/affect_behav | 0.50459901 |
| 141 | MP0002693_abnormal_pancreas_physiology | 0.49744989 |
| 142 | MP0009697_abnormal_copulation | 0.48265947 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.47467777 |
| 144 | MP0000920_abnormal_myelination | 0.46900286 |
| 145 | MP0002064_seizures | 0.46606197 |
| 146 | MP0004381_abnormal_hair_follicle | 0.46246448 |
| 147 | MP0003866_abnormal_defecation | 0.45651080 |
| 148 | MP0005167_abnormal_blood-brain_barrier | 0.45014770 |
| 149 | MP0002938_white_spotting | 0.42905434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 9.48029957 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 8.25136023 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.28854169 |
| 4 | Absent/shortened dynein arms (HP:0200106) | 6.28854169 |
| 5 | Loss of speech (HP:0002371) | 6.04264744 |
| 6 | Testicular atrophy (HP:0000029) | 5.61663836 |
| 7 | Obstructive lung disease (HP:0006536) | 5.58011592 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 5.58011592 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 5.54934271 |
| 10 | Cerebral palsy (HP:0100021) | 5.45039338 |
| 11 | Recurrent abscess formation (HP:0002722) | 5.04411777 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.96332912 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.96332912 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.96332912 |
| 15 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.75917380 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 4.37392893 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.29634408 |
| 18 | Chin dimple (HP:0010751) | 3.94127738 |
| 19 | Abnormal ciliary motility (HP:0012262) | 3.85080983 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59393572 |
| 21 | Poor head control (HP:0002421) | 3.56325094 |
| 22 | Abnormality of the pleura (HP:0002103) | 3.48448763 |
| 23 | Arthropathy (HP:0003040) | 3.41349866 |
| 24 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.40951521 |
| 25 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.40951521 |
| 26 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.35090067 |
| 27 | Meningitis (HP:0001287) | 3.33604372 |
| 28 | Hemoptysis (HP:0002105) | 3.29242890 |
| 29 | Acrocyanosis (HP:0001063) | 3.28769308 |
| 30 | Vasculitis (HP:0002633) | 3.23879665 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.21065416 |
| 32 | Hypoproteinemia (HP:0003075) | 3.21018709 |
| 33 | Short tibia (HP:0005736) | 3.20047033 |
| 34 | Macular degeneration (HP:0000608) | 3.17539311 |
| 35 | Azoospermia (HP:0000027) | 3.13699519 |
| 36 | Progressive visual loss (HP:0000529) | 3.02210937 |
| 37 | Progressive microcephaly (HP:0000253) | 3.01700003 |
| 38 | Hydroxyprolinuria (HP:0003080) | 2.94665537 |
| 39 | Abnormality of proline metabolism (HP:0010907) | 2.94665537 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.93410115 |
| 41 | Optic neuritis (HP:0100653) | 2.93410115 |
| 42 | Recurrent sinusitis (HP:0011108) | 2.89483850 |
| 43 | Chronic otitis media (HP:0000389) | 2.86476151 |
| 44 | Increased IgM level (HP:0003496) | 2.82550184 |
| 45 | Ankyloglossia (HP:0010296) | 2.77454940 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76030710 |
| 47 | Abnormality of the pericardium (HP:0001697) | 2.74292629 |
| 48 | Abnormality of B cell number (HP:0010975) | 2.69693589 |
| 49 | Recurrent skin infections (HP:0001581) | 2.64354594 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.64318498 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.63563561 |
| 52 | Nephritis (HP:0000123) | 2.60382184 |
| 53 | Glomerulopathy (HP:0100820) | 2.59985979 |
| 54 | Xerostomia (HP:0000217) | 2.59790101 |
| 55 | Paralysis (HP:0003470) | 2.59399985 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.58890366 |
| 57 | Abnormality of complement system (HP:0005339) | 2.58472973 |
| 58 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.57690298 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.56703360 |
| 60 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.50588084 |
| 61 | Prolonged partial thromboplastin time (HP:0003645) | 2.46368491 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.46188720 |
| 63 | Prostate neoplasm (HP:0100787) | 2.44994953 |
| 64 | Neoplasm of the colon (HP:0100273) | 2.43279320 |
| 65 | Gingivitis (HP:0000230) | 2.38129862 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.37932071 |
| 67 | Myositis (HP:0100614) | 2.37062471 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.36102210 |
| 69 | Pancreatic cysts (HP:0001737) | 2.34161717 |
| 70 | Orchitis (HP:0100796) | 2.33894100 |
| 71 | Thyroiditis (HP:0100646) | 2.32554787 |
| 72 | Fair hair (HP:0002286) | 2.31220441 |
| 73 | Reduced antithrombin III activity (HP:0001976) | 2.28757077 |
| 74 | Gangrene (HP:0100758) | 2.26006075 |
| 75 | Ureteral stenosis (HP:0000071) | 2.22584798 |
| 76 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.21997324 |
| 77 | Hypoplasia of the fovea (HP:0007750) | 2.21997324 |
| 78 | Chromsome breakage (HP:0040012) | 2.17791947 |
| 79 | Ureteral obstruction (HP:0006000) | 2.16546674 |
| 80 | Abnormal spermatogenesis (HP:0008669) | 2.14360441 |
| 81 | J-shaped sella turcica (HP:0002680) | 2.14314290 |
| 82 | Abnormality of oral frenula (HP:0000190) | 2.13349365 |
| 83 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13238033 |
| 84 | Hypoplasia of the thymus (HP:0000778) | 2.13031838 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.12544580 |
| 86 | Abnormality of male internal genitalia (HP:0000022) | 2.11523653 |
| 87 | Skin rash (HP:0000988) | 2.10964574 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.09931389 |
| 89 | Aplastic anemia (HP:0001915) | 2.09847060 |
| 90 | Eosinophilia (HP:0001880) | 2.09234512 |
| 91 | Pulmonary fibrosis (HP:0002206) | 2.08617425 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.08287399 |
| 93 | Parakeratosis (HP:0001036) | 2.07976980 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 2.06507010 |
| 95 | Tetraparesis (HP:0002273) | 2.03870957 |
| 96 | Lip pit (HP:0100267) | 2.02844896 |
| 97 | Stomatitis (HP:0010280) | 2.01128159 |
| 98 | Abnormality of the fovea (HP:0000493) | 2.00605509 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99940552 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99940552 |
| 101 | Median cleft lip (HP:0000161) | 1.98371428 |
| 102 | Tinnitus (HP:0000360) | 1.97087408 |
| 103 | Abnormality of midbrain morphology (HP:0002418) | 1.96890698 |
| 104 | Molar tooth sign on MRI (HP:0002419) | 1.96890698 |
| 105 | Anorexia (HP:0002039) | 1.95741043 |
| 106 | Recurrent viral infections (HP:0004429) | 1.95201527 |
| 107 | Tubulointerstitial nephritis (HP:0001970) | 1.94096835 |
| 108 | Emphysema (HP:0002097) | 1.92921941 |
| 109 | Chest pain (HP:0100749) | 1.92415211 |
| 110 | IgG deficiency (HP:0004315) | 1.91451227 |
| 111 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91160782 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.89461350 |
| 113 | Paresthesia (HP:0003401) | 1.88949862 |
| 114 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88757510 |
| 115 | Abnormal glucose tolerance (HP:0001952) | 1.88119623 |
| 116 | Combined immunodeficiency (HP:0005387) | 1.87675603 |
| 117 | Hematuria (HP:0000790) | 1.87388160 |
| 118 | Pruritus (HP:0000989) | 1.86974729 |
| 119 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.86405061 |
| 120 | Congenital sensorineural hearing impairment (HP:0008527) | 1.86248241 |
| 121 | Decreased central vision (HP:0007663) | 1.84883470 |
| 122 | Panhypogammaglobulinemia (HP:0003139) | 1.84845509 |
| 123 | Recurrent pneumonia (HP:0006532) | 1.83376516 |
| 124 | Restrictive lung disease (HP:0002091) | 1.82495092 |
| 125 | Arterial thrombosis (HP:0004420) | 1.80888111 |
| 126 | Gingival bleeding (HP:0000225) | 1.80697461 |
| 127 | Gastrointestinal infarctions (HP:0005244) | 1.80004438 |
| 128 | Malnutrition (HP:0004395) | 1.79619729 |
| 129 | IgM deficiency (HP:0002850) | 1.79348195 |
| 130 | IgA deficiency (HP:0002720) | 1.77556283 |
| 131 | White forelock (HP:0002211) | 1.77536996 |
| 132 | Methylmalonic acidemia (HP:0002912) | 1.76769972 |
| 133 | Abnormality of the axillary hair (HP:0100134) | 1.75978939 |
| 134 | Abnormality of secondary sexual hair (HP:0009888) | 1.75978939 |
| 135 | Vertigo (HP:0002321) | 1.75707105 |
| 136 | Abnormality of binocular vision (HP:0011514) | 1.75582326 |
| 137 | Diplopia (HP:0000651) | 1.75582326 |
| 138 | Increased serum ferritin (HP:0003281) | 1.75174227 |
| 139 | Exertional dyspnea (HP:0002875) | 1.74785766 |
| 140 | Septo-optic dysplasia (HP:0100842) | 1.74438937 |
| 141 | Pulmonary embolism (HP:0002204) | 1.74434554 |
| 142 | Abnormal drinking behavior (HP:0030082) | 1.74315808 |
| 143 | Polydipsia (HP:0001959) | 1.74315808 |
| 144 | Lymphoma (HP:0002665) | 1.74198085 |
| 145 | Joint hemorrhage (HP:0005261) | 1.73843653 |
| 146 | B lymphocytopenia (HP:0010976) | 1.71968633 |
| 147 | Stomach cancer (HP:0012126) | 1.71451606 |
| 148 | Granulocytopenia (HP:0001913) | 1.68833715 |
| 149 | Osteomyelitis (HP:0002754) | 1.68547118 |
| 150 | Cardiomegaly (HP:0001640) | 1.66903717 |
| 151 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.66715814 |
| 152 | Severe muscular hypotonia (HP:0006829) | 1.66621003 |
| 153 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.65342305 |
| 154 | Fibular aplasia (HP:0002990) | 1.65167415 |
| 155 | Febrile seizures (HP:0002373) | 1.64507659 |
| 156 | Heterochromia iridis (HP:0001100) | 1.63998547 |
| 157 | Leukocytosis (HP:0001974) | 1.63991981 |
| 158 | Clubbing of toes (HP:0100760) | 1.63714204 |
| 159 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.62826205 |
| 160 | Short 1st metacarpal (HP:0010034) | 1.62826205 |
| 161 | Erythroderma (HP:0001019) | 1.62684328 |
| 162 | Mucosal telangiectasiae (HP:0100579) | 1.61736784 |
| 163 | Abnormality of renin-angiotensin system (HP:0000847) | 1.61566802 |
| 164 | Keratoconjunctivitis sicca (HP:0001097) | 1.59872506 |
| 165 | Bifid uvula (HP:0000193) | 1.59767830 |
| 166 | Abnormal biliary tract physiology (HP:0012439) | 1.59221801 |
| 167 | Congenital stationary night blindness (HP:0007642) | 1.58145927 |
| 168 | Patchy hypopigmentation of hair (HP:0011365) | 1.57206689 |
| 169 | Congenital, generalized hypertrichosis (HP:0004540) | 1.56847717 |
| 170 | Pulmonary artery stenosis (HP:0004415) | 1.56446722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.54707662 |
| 2 | MAP3K11 | 4.33376119 |
| 3 | TXK | 4.02728787 |
| 4 | MAP3K14 | 3.69095866 |
| 5 | MAP3K12 | 3.68241026 |
| 6 | EPHA4 | 3.50682601 |
| 7 | IRAK4 | 3.34621239 |
| 8 | STK39 | 2.63396637 |
| 9 | RIPK1 | 2.60329047 |
| 10 | TAOK2 | 2.50460220 |
| 11 | BLK | 2.38026563 |
| 12 | IRAK3 | 2.33924257 |
| 13 | TBK1 | 2.26749023 |
| 14 | RIPK4 | 2.22731044 |
| 15 | CSF1R | 2.09758782 |
| 16 | TYK2 | 2.06320461 |
| 17 | IKBKB | 2.05572644 |
| 18 | BMPR1B | 2.04230544 |
| 19 | GRK1 | 2.03902265 |
| 20 | ITK | 2.03361925 |
| 21 | SIK3 | 1.95298936 |
| 22 | JAK1 | 1.88901820 |
| 23 | SYK | 1.87735366 |
| 24 | ZAK | 1.87495342 |
| 25 | NEK1 | 1.82880570 |
| 26 | NUAK1 | 1.82533920 |
| 27 | TNIK | 1.81931996 |
| 28 | KIT | 1.72912181 |
| 29 | BMPR2 | 1.71028451 |
| 30 | TLK1 | 1.67269569 |
| 31 | LYN | 1.48918833 |
| 32 | CASK | 1.47276835 |
| 33 | WNK3 | 1.41027087 |
| 34 | ACVR1B | 1.40178725 |
| 35 | TEC | 1.40111274 |
| 36 | CSK | 1.37646636 |
| 37 | PBK | 1.37461612 |
| 38 | MAP4K2 | 1.35452122 |
| 39 | MARK3 | 1.33923806 |
| 40 | MAP2K6 | 1.32188593 |
| 41 | IKBKE | 1.31535337 |
| 42 | ERBB3 | 1.30132942 |
| 43 | STK16 | 1.27012530 |
| 44 | TAOK3 | 1.26647929 |
| 45 | MYLK | 1.20974316 |
| 46 | WNK4 | 1.19922146 |
| 47 | EIF2AK2 | 1.19354288 |
| 48 | MST4 | 1.16163513 |
| 49 | ADRBK2 | 1.12851940 |
| 50 | BRSK2 | 1.11777580 |
| 51 | FES | 1.08702534 |
| 52 | PAK3 | 1.08112328 |
| 53 | PKN1 | 1.06898611 |
| 54 | PRKCQ | 1.06250958 |
| 55 | STK24 | 1.04510075 |
| 56 | JAK3 | 1.03051974 |
| 57 | CDK19 | 0.97499524 |
| 58 | HCK | 0.96470278 |
| 59 | YES1 | 0.93975800 |
| 60 | MAPKAPK3 | 0.93713862 |
| 61 | MAP3K4 | 0.92733979 |
| 62 | NEK2 | 0.89635519 |
| 63 | CLK1 | 0.84419977 |
| 64 | PRPF4B | 0.83514162 |
| 65 | BTK | 0.81601664 |
| 66 | CHUK | 0.81228599 |
| 67 | MELK | 0.78581715 |
| 68 | MAP3K9 | 0.78311104 |
| 69 | NEK6 | 0.75986810 |
| 70 | NEK9 | 0.74594201 |
| 71 | GRK7 | 0.74178837 |
| 72 | FGR | 0.73179061 |
| 73 | PRKCD | 0.71950807 |
| 74 | MAP3K5 | 0.68153982 |
| 75 | LCK | 0.66516677 |
| 76 | PLK2 | 0.66331121 |
| 77 | TNK2 | 0.65138934 |
| 78 | TAF1 | 0.65096373 |
| 79 | AURKA | 0.64637761 |
| 80 | FER | 0.62393866 |
| 81 | DAPK2 | 0.62056313 |
| 82 | PRKCZ | 0.60844730 |
| 83 | PRKCE | 0.56790523 |
| 84 | OXSR1 | 0.55542200 |
| 85 | MAP2K7 | 0.55193192 |
| 86 | TYRO3 | 0.54362640 |
| 87 | MKNK2 | 0.54178339 |
| 88 | PTK2B | 0.53209878 |
| 89 | TRPM7 | 0.52900234 |
| 90 | MATK | 0.52100138 |
| 91 | CSNK1A1L | 0.51786749 |
| 92 | NLK | 0.51445654 |
| 93 | FGFR3 | 0.49960023 |
| 94 | PIM1 | 0.49672203 |
| 95 | PIM2 | 0.49070694 |
| 96 | VRK1 | 0.48567446 |
| 97 | MUSK | 0.46109612 |
| 98 | EIF2AK1 | 0.45970632 |
| 99 | PIK3CG | 0.45420396 |
| 100 | NTRK3 | 0.44795938 |
| 101 | CSNK1G1 | 0.44719392 |
| 102 | EPHB1 | 0.44488714 |
| 103 | CAMK1 | 0.44090584 |
| 104 | PDK1 | 0.42435273 |
| 105 | HIPK2 | 0.38528268 |
| 106 | STK4 | 0.38291716 |
| 107 | IRAK1 | 0.38290457 |
| 108 | JAK2 | 0.38092701 |
| 109 | PRKAA2 | 0.37163854 |
| 110 | ABL1 | 0.36686929 |
| 111 | SRPK1 | 0.36626262 |
| 112 | FRK | 0.35071815 |
| 113 | TIE1 | 0.33876415 |
| 114 | PRKACA | 0.33601893 |
| 115 | GRK5 | 0.32799002 |
| 116 | IGF1R | 0.31593864 |
| 117 | STK3 | 0.31087157 |
| 118 | IRAK2 | 0.30847766 |
| 119 | DAPK3 | 0.30819226 |
| 120 | CSNK1G3 | 0.30757833 |
| 121 | BCR | 0.30673848 |
| 122 | ADRBK1 | 0.29834355 |
| 123 | PRKACG | 0.29365363 |
| 124 | AKT3 | 0.28727750 |
| 125 | MAP3K3 | 0.28460326 |
| 126 | ZAP70 | 0.27778773 |
| 127 | TGFBR2 | 0.27736743 |
| 128 | MAPK13 | 0.26352003 |
| 129 | RPS6KB1 | 0.25380071 |
| 130 | CAMKK1 | 0.24965488 |
| 131 | EPHA3 | 0.24153505 |
| 132 | INSRR | 0.23652888 |
| 133 | MAPK7 | 0.22121641 |
| 134 | CDK3 | 0.21746570 |
| 135 | MAP3K13 | 0.20176162 |
| 136 | PRKG1 | 0.19890412 |
| 137 | MAPK3 | 0.18928731 |
| 138 | CAMK2A | 0.18636156 |
| 139 | PRKCA | 0.17374613 |
| 140 | SGK1 | 0.17046131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.30264598 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.08386261 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.70735790 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68675068 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.63477779 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.42567416 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.34053190 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.32003331 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16981103 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.14272345 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10092459 |
| 12 | Salmonella infection_Homo sapiens_hsa05132 | 2.01550143 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82735111 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.78851571 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77142728 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.74958195 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.71158395 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71093918 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68124564 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67670969 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.67023023 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65158247 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.62979588 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62145689 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.61203256 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.59171965 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57531916 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.55626448 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.55132368 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54352987 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51207972 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49074855 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45458701 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45443038 |
| 35 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42178440 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37425951 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36943766 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33131614 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31316250 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.29557028 |
| 41 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28497297 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27160136 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.20862770 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19983177 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18350149 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18328712 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09891629 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09297602 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00069515 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98271754 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98180093 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94849278 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92155681 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90851038 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.90061406 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89410136 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88547110 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87613550 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85646672 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84511584 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83199923 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81714373 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81518903 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79987440 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.76220833 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72833374 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72788152 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70717393 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70328408 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.70289201 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70244047 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67952598 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.67765775 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65925830 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64657358 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63618437 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63404722 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62561732 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.60502268 |
| 80 | Proteasome_Homo sapiens_hsa03050 | 0.59431585 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.59228101 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56844958 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.55735883 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54930806 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54078638 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51860786 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51500265 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.50558983 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.50439479 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48486261 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47674892 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46223389 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45938671 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42408531 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42121141 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42030352 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41206884 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41084692 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40766065 |
| 100 | RNA polymerase_Homo sapiens_hsa03020 | 0.40425412 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40005843 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39974878 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39561527 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39524756 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39458703 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39257476 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37971319 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37647296 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.37343687 |
| 110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36988051 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34630708 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.33912934 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33560337 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32562180 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32161942 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31884507 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31788859 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31220382 |
| 119 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31162060 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31111396 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30777496 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30611610 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29338802 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29201788 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27135369 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26227382 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25346545 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23626707 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18120609 |
| 130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.16795519 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14976582 |
| 132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.09028467 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08778116 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.08470094 |
| 135 | Peroxisome_Homo sapiens_hsa04146 | 0.06835324 |
| 136 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.03988679 |

